Top 50 Medical VC (Venture Capital) Funds in Australia in May 2025
A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Australia. We rank investors based on the number of investments they made in Medical companies from Australia. We update this investor list every month.Top 50 Medical VC (Venture Capital) Funds in Australia in May 2025
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- AdvanCell — AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Australia, United States, Hong Kong
Portfolio highlights
- Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
- Modern Synthesis — Combining biology, material science, engineering and human ingenuity, we create textiles that are circular by nature, and customisable by design.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Diraq — Diraq uses spins in silicon quantum dots as qubits. Diraq's qubits are compatible with existing CMOS processes and can fit billions of qubits on a single chip. To transform our world, quantum computers need billions of qubits and Diraq has the IP, the team and the plan to get there.
- Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Funding Round, Series A
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Series B
- Australia, United States, Philippines
Portfolio highlights
- Levur — Levur produces oils inspired by nature, without the environmental impact. Our vision is a future where reliance on unsustainable plant and animal oils like Palm Oil is drastically reduced, mitigating environmental impacts. We are collaborating with large consumer goods manufacturers to make this a
- Arkeus — Arkeus is a leader in the fusion of optics and autonomy. Our wide area autonomous optical systems are deployed to conduct Search, Intelligence, Surveillance and Reconnaissance in a range of operating environments.
- QuintessenceLabs — Quantum cyberattacks can break current encryption in minutes! Get protected with QuintessenceLabs quantum key distribution, generation, and management.
Right Click Capital - Australian Venture Capital Firm
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Funding Round
- Australia, Singapore, United States
Portfolio highlights
- black.ai — Build smarter spaces with Black.ai
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more
Investment focus
- SaaS, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- Australia, United States
Portfolio highlights
- Kapiche — Top-rated customer feedback analytics platform. Instant insights. No setup or coding. Kapiche ingests & analyzes feedback in minutes for real customer insights.
- FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
- Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more
Investment focus
- Health Care, Information Technology, SaaS
- Seed, Series A, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- Modo — Declutter your mind with our app to boost your mental wellbeing and productivity. modo helps you be present in the moment and focus on what matters most.
- Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
- More Good Days — More Good Days offers evidence-based pain management programes, education, and health services.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Software
- Series A, Series B, Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
- Owlstone Medical — Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory disease, and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs.The company’s Breath Biopsy® platform has introduced a new diagnostic modality making it possible to discover novelnon-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA Breath Sampler ensures a reliable collection of breath samples. The volatile organic compounds (VOCs) present in the breath are analyzed using proven microchip chemical sensor technology (FAIMS) to detect biomarkers of disease.The Breath Biopsy platform can be used in clinical diagnostics and precision medicine with applications in cancer and a wide range of other medical conditions. Highly sensitive and selective, these tests allow for early diagnosis when treatments are more effective and more lives can be saved.Owlstone Medical is currently developing tests for lung and colorectal cancer, two of the most common cancer killers worldwide, and for asthma stratification by the therapeutic response. The company also Breath Biopsy products and services to academic, clinical, and pharma partners who want to develop breath-based diagnostics for their own applications.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Pre-Seed
- Australia, United States, New Zealand
Portfolio highlights
- Ravio — Ravio allows you to understand compensation in your market in real-time. Make smarter salary, equity and benefits decisions without touching a spreadsheet.
- Blinq — Blinq makes it easy to share your contact details via QR code scanning on the mobile app.
- Wonder Studios — Producing world-class original content
Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.
Show more
Investment focus
- Medical, Facial Recognition, Artificial Intelligence
- Seed, Funding Round
- Australia
Portfolio highlights
- Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
- Software, Health Care, SaaS
- Seed, Angel, Series A
- Australia, United States
Portfolio highlights
- Okkular — Okkular is an AI based fashion tech startup.
- Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Show more
Investment focus
- Software, Financial Services, FinTech
- Seed, Series A, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Qlarifi — Consumer lending decisions transformed with real time, comprehensive data.
- Safewill — Safewill is Australia's leading online Will writing platform. With thousands of users, Safewill makes it easy and affordable to write your own legally binding will
- Ajust — Ajust makes it easy to resolve customer complaints with banks, telcos and energy companies. It's fast, fair and free for consumers.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
- Software, Financial Services, FinTech
- Funding Round, Series B, Convertible Note
- Australia, United States, United Kingdom
Portfolio highlights
- Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
- Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
- Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.
Show more
Investment focus
- Software, E-Commerce, Health Care
- Seed, Series A, Funding Round
- Australia, United States
Portfolio highlights
- OpusXenta — Byond is comprehensive business management software for cemeteries & crematoria, streamlining operations with mapping, record-keeping, sales management and more.
- PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
- FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
- Software, Enterprise Software, Information Technology
- Series A, Series B, Funding Round
- United States, Australia, Philippines
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,281,559 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
- Software, Apps, Information Technology
- Seed, Series A, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
- SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
- Forever Network — Forever Network is a social-first sports media company. Our keystone brand, Basketball Forever, is the worlds largest independent sports media channel.
Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.
Show more
Investment focus
- Construction, Software, SaaS
- Funding Round, Seed, Convertible Note
- Australia, United States
Portfolio highlights
- SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
- APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.
Show more
Investment focus
- Software, SaaS, Information Technology
- Series A, Seed, Funding Round
- Australia, New Zealand, United States
Portfolio highlights
- splose — splose isn’t just practice management software. It's your ally in handling the ins-and-outs of running a practice and a savvy tool for growth. At splose, we are dedicated to continuously improving and embracing the power of AI and automation to give healthcare professionals like you more time to focus on what matters most.
- Nexl — Nexl believes that CRM systems should be easy-to-use, affordable, and fully automated. They made it their mission to enable law firm's around the world to take back control over their business development efforts and enable them to grow at their full potential.
- InvestorHub — We provide comprehensive access to listed capital raises for institutional, family office and high net worth investors.
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.
Show more
Investment focus
- Events, Sports, Cycling
- Pre-Seed
- Hong Kong
Portfolio highlights
- Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
- VueMotion Labs — Optimize athletic performance with VueMotion's AI-driven movement analysis. Accessible, affordable, and trusted by pro teams worldwide. Start testing today!
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Seed, Series A
- Australia
Portfolio highlights
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
- VitalTrace — VitalTrace is a medical device company helps mothers and children during labour and delivery by innovating new monitoring devices.
Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.
Show more
Investment focus
- EdTech, Medical, Education
- Seed
- Australia
Portfolio highlights
- PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
- My Mirror — Find the right online psychologist in Australia, tailored to your needs and schedule. Start online therapy today with no wait times. Book now, pay later
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Series A
- Australia
Portfolio highlights
- Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Queensland Investment Corporation is an investment company.
Show more
Investment focus
- Information Technology, Software, Financial Services
- Seed, Series A, Funding Round
- Australia, United States
Portfolio highlights
- Gelomics — Gelomics operates as a biotechnology company. Gelomics provides 3D cell culture technologies.
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Renewa — Renewa is a top renewable energy land & infrastructure investor that buys land, ground leases, & royalties to help landowners attain financial security.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more
Investment focus
- Manufacturing, Health Care, Software
- Funding Round, Series A, Seed
- Australia, United States, Philippines
Portfolio highlights
- EntroMat — EntroMat is a pioneering deep-tech startup transforming the metal powder industry through the advancement of high entropy material (HEM) powders.
- Umps Health — Umps offers a 24/7 personal alarm that helps you live independently with peace of mind. Easy to use, always connected.
- Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Skip Capital is a private investment fund investing in technology and infrastructure
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Series A, Seed, Series B
- Australia, United States, Canada
Portfolio highlights
- Askable — Askable offers a comprehensive research platform that facilitates access to certified researchers and verified participants globally. The platform streamlines the research process from recruitment to analysis, enabling teams to gather insights efficiently.
- Lorikeet — Lorikeet provides AI customer support. Lorikeet offer its customers responsive, personalized, and effective support as table stakes.
- GROWL — Discover GROWL: the smart boxing bag blending cardio, strength, and gaming. Experience an immersive home boxing coach and step up your performance.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A
- Australia
Portfolio highlights
- Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
- Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Series C
- United States, United Kingdom, Canada
Portfolio highlights
- Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
- VieCure — The VieCure platform is an Clinical Decision Support solution in Oncology that combines the power of artificial intelligence, codified clinical rules and pathways, precision oncology, telehealth, smartphone technology, and the EMR to transform cancer care.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A, Debt Financing, Funding Round
- Australia, United States, Israel
Portfolio highlights
- Hometime — At Hometime, we provide Airbnb property management solutions for homeowners and rental management business owners that help them scale and earn more.
- StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
- Employment Hero — Employment Hero operates as an online human resource platform for small and medium-sized businesses. Its cloud-based HR platform combines HR software, financial services, scheduling, and payroll tools, as well as employee benefits, providing growing companies with an intuitive, affordable way to manage essential employee information and HRprocesses. The company aims to become the employment platform of choice for employers and employees in Australia and beyond, by providing free, easy-to-use HR software that employers love to use, and access to far greater benefits for all employees.Employment Hero was founded in 2014 and is headquartered in Sydney New South Wales.
Titanium Ventures is the results-oriented VC partner to the most promising technology startups. Accelerating extraordinary companies and fueling growth of standout disruptors.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Series B, Series C, Series A
- United States, China, Australia
Portfolio highlights
- BuildOps — The only commercial management software built specifically for commercial trade businesses. Improve efficiency and increase profitability with BuildOps. seeed home
- Flex — 10x higher credit limit. 0% interest for 60 days. No personal guarantee. No personal liability for construction
- Bedrock Energy — Bedrock Energy is developing drilling technology and advanced subsurface simulation software to enable geothermal heating and cooling. The company develops autonomous drilling technology and advanced subsurface simulation software to make geothermal heating and cooling more widespread, affordable, and accessible.
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
Show more
Investment focus
- Medical, Health Care, Therapeutics
- Pre-Seed
- Australia
Portfolio highlights
- Cell Bauhaus — Cell Bauhaus uses mathematical and computer modeling to understand, predict, and modify living cell behavior, aiming to expedite sustainable solutions to humanity's pressing issues.
- Remagine Labs — Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world.
- Psychae Therapeutics — Psychae Therapeutics develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses
Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.
Show more
Investment focus
- Software, Information Technology, E-Commerce
- Seed, Series A, Pre-Seed
- Australia, United States, Singapore
Portfolio highlights
- Grw AI — Grw AI offers scalable 1:1 coaching solutions that leverage AI to assist B2B sales teams complete deals.
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
AirTree is a venture capital firm investing in Australian and New Zealand technology founders from seed stage or earlier.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Series B
- Australia, United States, Singapore
Portfolio highlights
- Haast — Haast is an artificial intelligence SAAS company that offers marketing compliance automation services.
- Gridsight — Gridsight helps electrical utilities transition to a decentralised grid by creating 90%-accurate, AI-powered load flow models. These models enable utilities to safely and efficiently support more residential solar, batteries and electric vehicles. Based on CEO Brendan Banfield's PhD research, Gridsight was founded in 2020 to accelerate the transition to renewables.
- Harmony Intelligence — AI cybersecurity products that solve your AppSec, SecOps, and corporate security challenges.
Side Stage Ventures is a founder-led seed fund backing outlier founders in Australia. We write the first cheque into the best early stage companies. Then we lean in to help the founders build & scale.
Show more
Investment focus
- Information Technology, Content, Medical
- Seed, Series A
- Australia
Portfolio highlights
- TrueState — Accelerate your AI adoption with TrueState's library of high-impact AI solutions, infinitely customisable for your unique business context.
- Thanks — Delight your most valuable customers at the moment of checkout and start unlocking new revenue with Thanks.
- Arca Climate Technologies, Inc. — Carbin Minerals unlock the enormous carbon dioxide removal potential of mine waste.
AustralianSuper is run only to benefit members, offering low fees and strong long-term investment returns.
Show more
Investment focus
- Information Technology, Hotel, Solar
- Funding Round, Series A, Series C
- Australia, United States, United Kingdom
Portfolio highlights
- Peel Ports — Peel Ports is a unique network of strategically situated ports, terminals, hubs, shipping lines, and state-of-the-art services.
- SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
- Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
- Biotechnology, Information Technology, Manufacturing
- Angel, Seed, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
- Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
- Alkira Software — Deliver interactive content and answer customer queries at scale using conversational AI. TalkVia offers quick and easy NO CODE voice and chat solutions for Amazon Alexa, Google Assistant, Siri and web based chatbots.
With origins in owning and operating Australian pharmacies, Soul Patts has evolved into a diversified investment house investing across a range of industries and asset classes, including listed equities, private equity, credit, and property.
Show more
Investment focus
- Software, Hotel, Men's
- Funding Round, Series A
- Australia
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
- InStitchu — InStitchu is an online custom clothier specializing in tailor made menswear. Customers are able to design custom made garments online which are then made to their exact measurements.InStitchu provides tailor made, high quality menswear through a simple online ordering process. Once a customer has added measurements to their profile, a suit orshirt can be ordered in a few minutes and on its way in two weeks. There are multiple ways for a customer to get their measurements perfected and enjoy that “perfect fit” InStitchu customers keep coming back for - our measurement guide will take you on a journey from your living room to the hustle and bustle of our tailor’s studio. Customers can choose from a wide range of globally sourced high quality wool and cotton fabrics, and when you’ve chosen, we’ll deliver your design right to your door. This new approach to shopping is stress free and cuts out the middleman, allowing us to deliver customers luxury tailor made suits and shirts without the high price tag.
- SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
Jelix is an early-stage venture capital firm backing daring founders in Australia and New Zealand.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Funding Round
- Australia, New Zealand, United States
Portfolio highlights
- Fugu — Cheap green carbon at scale for the dawn of the e-fuel age
- Fugu Carbon — Fugu Carbon is a machinery manufacturing company that helps in carbon dioxide removal (CDR) technology from air.
- Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the lifescience community to achieve superior returns for their group, and more clinical innovation for the community.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- United States, Israel, Australia
Portfolio highlights
- Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
- Capillary Biomedical — Make diabetes management easier with insulin pumps and other innovative products and services from Tandem Diabetes Care.
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.
Show more
Investment focus
- Medical, Software, Health Care
- Series A
- Australia
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Debt Financing
- United Kingdom, Australia, United States
Portfolio highlights
- Driverly — Driverly is an Insurtech based in Cardiff, Wales, with a mission to bring insurance to the 21st century. We offer AI-powered Insurance Intelligence at different stages of the customer life cycle.
- nisien.ai — Industry-leading artificial and human intelligence for effective and ethical online safeguarding with Nisien AI.
- Lumin Solutions —
Great tech startup businesses are built by amazing product teams
Show more
Investment focus
- Medical, Health Care, Pharmaceutical
- Seed
- Australia
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
Larsen Ventures is a lean, driven and strategic venture investment firmWe believe in alignment, long-term thinking & investor due diligence
We like metrics, traction & perseverance
We invest in people
1/3 of our focus is on Health and Education;
We like the thematic & overall gains for society2/3 of our time is spentlearning from peers, digging into research,
chasing leads & hanging out on caffeinated zooms in the endless search for;Founders with Traction
Founders with Insight
Founders with Perseverance and Courage
Founders with an innate ability to question EverythingWe have patient capital that engages & contributes to your Journey
Accelerate your business with our portfolios' intellectual capital
Show more
Investment focus
- Software, Education, SaaS
- Seed, Series A, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Go1 — GO1 provides a platform that allows companies to upscale their workforce with on-demand training and a dynamic content-driven platform for companies that are Open to Learn. The funding follows an integration with Microsoft Teams, which enables organizations using Teams to learn directly within their workplace ecosystem. Individuals can now find,consume, share, and discuss learning resources from its library of online learning resources.
- Edstart — Edstart | A better Way to Pay School Fees
- Vitruvian Form — Vitruvian manufactures a connected fitness hardware, develops software and fitness class content.
Seven West Media is the leading, listed national multi-platform media business based in Australia. We comprise Seven Television, the leading free to air capital city television network; Pacific Magazines, the country's second largest magazine group by readership; Yahoo!7 one of the nation’s most successful internet platforms, as well asWestern Australia's leading newspaper, The West Australian and associated WA regional newspapers and radio stations. Seven West Media was created through the acquisition of Seven Media Group by West Australian Newspapers Holdings Limited (WAN) as approved by WAN shareholders on 11 April 2011.
Show more
Investment focus
- Software, Financial Services, Internet
- Funding Round, Seed, Series C
- Australia, United States
Portfolio highlights
- Carbar — Carbar is Australia's first and leading vehicle subscription service. Carbar started off as a virtual car dealership that streamlines the process of selling and buying cars. It also offers a car subscription service, an alternative to car ownership where a customer can get to use a car for a recurring fee. Their car subscription serviceincludes no fixed term-contracts, fully inclusive of insurance, registration, maintenance, roadside assistance and the ability to switch cars depending on your needs.Carbar was founded in 2016.
- InStitchu — InStitchu is an online custom clothier specializing in tailor made menswear. Customers are able to design custom made garments online which are then made to their exact measurements.InStitchu provides tailor made, high quality menswear through a simple online ordering process. Once a customer has added measurements to their profile, a suit orshirt can be ordered in a few minutes and on its way in two weeks. There are multiple ways for a customer to get their measurements perfected and enjoy that “perfect fit” InStitchu customers keep coming back for - our measurement guide will take you on a journey from your living room to the hustle and bustle of our tailor’s studio. Customers can choose from a wide range of globally sourced high quality wool and cotton fabrics, and when you’ve chosen, we’ll deliver your design right to your door. This new approach to shopping is stress free and cuts out the middleman, allowing us to deliver customers luxury tailor made suits and shirts without the high price tag.
- CarExpert.com.au — Australia's most reputable and independent motoring experts bring you the latest car reviews, comparisons, news and auto content.
CVC has seven complementary strategies across private equity, secondaries and credit, through which we invest on behalf of pension funds and other leading institutions
Show more
Investment focus
- Software, Financial Services, Retail
- Private Equity, Post-IPO Equity, Funding Round
- United States, United Kingdom, Indonesia
Portfolio highlights
- Odevo — We are on a mission to become the leading force within property management and residential services through the combined power of people and technology. Join us.
- Hempel — We help you protect your most valuable assets with our high-quality coatings
- DealStack — Dealstack is the operating system for private capital, built for private capital, by private capital professionals.
Square Peg is a global investment firm on a mission to empower exceptional founders. With investing teams in Sydney, Melbourne, Tel Aviv, and Singapore, Square Peg invests in emerging technology companies across the internet economy.
Show more
Investment focus
- Software, SaaS, Financial Services
- Seed, Series A, Series B
- Australia, United States, Israel
Portfolio highlights
- Neara — Predictive modeling software for proactive network governance. Quantify and prove network needs in any scenario. Run precise analyses in hours and days instead of months or years in the field.
- Qodo — Qodo (formerly CodiumAI) offers quality-first AI tools for developers to write, test, and review code directly within their IDE and Git.
- Lorikeet — Lorikeet provides AI customer support. Lorikeet offer its customers responsive, personalized, and effective support as table stakes.
Healthcare Ventures is an investment fund that invests in people and technologies that focuses on the data and technology of healthcare. Healthcare Ventures specializes in the fields of venture capital, private equity, and financial services.
Show more
Investment focus
Portfolio highlights
- Evidentli — Our technology standardises complex healthcare data with over 99% accuracy in days, not months; in weeks, not years.
Investors by industry
Impact
Biotech
Gaming
FinTech
Google
Energy
Proptech
Marketplace
Consumer
Hardware
Artificial intelligence
Health Care
Climate
Community
EdTech
Sustainability
Clean Energy
Venture Capital
Social Media
Medical
Real Estate
Internet
Manufacturing
eSports
Financial Services
Construction
Digital Media
Art
Local
Sports
Video Games
Music
Enterprise Software
Social Network
Wellness
B2B
Email
Franchise
Android
Mobile
Legal
Mobile Advertising
Platforms
Education
Cannabis
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Publishing
Automotive
Medical Device
Social
Crowdfunding
Wine And Spirits
CleanTech
Finance
Transportation
Mobile Apps
InsurTech
Food and Beverage
Enterprise
Beauty
Infrastructure
LGBT
Web3
Photography
Retail
Big Data
Organic Food
Payments
Fashion
Oil and Gas
Film
Life Science
Theatre
Non Profit
SaaS
Renewable Energy
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Cryptocurrency
Machine Learning
Facebook
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
United Kingdom
Germany
India
United States
Ireland
South Korea
Canada
Australia
New Zealand
Middle East
Oceania
Europe
Asia
South Africa
Armenia
Brazil
Qatar
Indonesia
Spain
China
Saudi Arabia
Sri Lanka
Finland
Vietnam
Estonia
Hungary
Ethiopia
Hong Kong
Africa
Georgia
Egypt
Ecuador
Denmark
France
Faroe Islands
LATAM
Ghana
Croatia
Gibraltar
Bulgaria
Chile
Belize
Barbados
Costa Rica
Greece
Belgium
Bahrain
Belarus
Japan
Bermuda
Czech Republic
Algeria
Mali
Mexico
Liberia
Israel
Philippines
Malaysia
Italy
Lithuania
Liechtenstein
Kuwait
Norway
Morocco
Myanmar
Lebanon
Mauritius
Peru
Jersey
Panama
Malta
Nicaragua
Sweden
El Salvador
Uruguay
Portugal
Zambia
Ukraine
Uzbekistan
Senegal
Seychelles
Venezuela
Tajikistan
Taiwan
Serbia
Uganda
Sierra Leone
Turkey
Thailand
Tunisia
San Marino
Rwanda
Puerto Rico
Poland
Russian Federation
Tanzania
Slovenia
Zimbabwe
Togo
Dominican Republic
Singapore
Azerbaijan
Nigeria
Bahamas
Namibia
Iceland
Iraq
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Grenada
Albania
Pakistan
Romania
Jordan
Argentina
Bangladesh
Kenya
Kazakhstan
Cayman Islands
Cambodia
Oman
Cyprus
Latvia
Colombia
Austria
Cameroon
Switzerland
Guatemala
Marshall Islands
VC (Venture Capital) Funds in Australia by industry
Transportation
Health Care
Consumer
Biotech
Climate
Energy
SaaS
Proptech
Marketplace
Hardware
Community
Restaurants
Crowdfunding
Venture Capital
Mobile Apps
Life Science
Oil and Gas
Real Estate
Finance
Cryptocurrency
Payments
InsurTech
Food and Beverage
Video Games
Social Network
Medical
Wellness
Email
Medical Device
Art
Social Media
Digital Media
Music
Manufacturing
Mobile
Internet
Android
Blockchain
Construction
FinTech
Enterprise
Software
Legal
eSports
Fitness
Hospitality
CleanTech
Automotive
Travel
Biotechnology
Cannabis
Social
Retail
Fashion
B2B
Beauty
Web3
Publishing
Big Data
Clean Energy
Education
Financial Services
Infrastructure
Non Profit
Wine And Spirits
Sports
Impact
EdTech
Renewable Energy
Gaming
Artificial intelligence
Machine Learning
Agriculture (agtech)
Media (entertainment)
Recruiting
Platforms
Sporting Goods
Sustainability
Social Impact
Enterprise Software